ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382050 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382050; 2) Community: the network communities that were significantly associated with the response to NSC 382050; 3) Molecule: the relationships between components within communities and NSC 382050; 4) MDR: the compounds that were significantly associated with the NSC 382050.

NSC Compound Enrichment Correlation
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.0115521552688258 0.40164377
NSC 740504 5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0115521552688258 0.26149561
NSC 100290 Doxypyrromycin hydrochloride 0.0123744972338278 0.32625475
NSC 113237 Null 0.0123744972338278 0.48835634
NSC 133072 Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) 0.0123744972338278 0.43620611
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0123744972338278 0.60137107
NSC 184692 Aminopterin Derivative 0.0123744972338278 0.60919632
NSC 207895 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0123744972338278 0.22856645
NSC 243022 Cinerubin A hydrochloride 0.0123744972338278 0.31865559
NSC 610459 Camptothecin Derivative 0.0123744972338279 0.25941451
Total:98  Current:31    [First] [Prev] [Next] [Last]